Takeda Pharmaceutical Company Limited (TSE:4502) signed an agreement to acquire OTC Medicines and Food Supplements from Unipharm Inc. for ¥40,800 million on January 26, 2018. The transaction is expected to be accretive to Takeda's Underlying Core Earnings, but will have minimal impact in FY2017.